trt and glp 1 trt and glp-1 GLP-1-based therapies for type 2 diabetes: from single, dual and GLP-1 Weight Loss Treatment &
Description
118 min
Major Players Novo Nordisk Eli Lilly Sanofi AstraZeneca Boehringer Ingelheim Merck & Co
Overall, GLP-1 RAs appear to be more efficacious than DPP4 inhibitors in people with type 2 diabetes in terms of improving glycaemic control and reducing body weight (Gilbert and Pratley, 2020)
Conclusions/interpretation In individuals with NAFLD and type 2 diabetes, GLP-1RAs are associated with lower incidences of adverse CVEs and all-cause mortality compared with metformin or other second- and third-line glucose-lowering medications
